首页> 外国专利> Antibody Conjugates (ADCS) - Active principle of KSP inhibitors with anti tweakr

Antibody Conjugates (ADCS) - Active principle of KSP inhibitors with anti tweakr

机译:抗体缀合物(ADCS)-具有抗调节作用的KSP抑制剂的活性成分

摘要

This application relates to conjugated Linker - Active Principle (ADCS), active Metabolites of these ADCS, procedures for preparing these ADCS,The use of these ADCS for Treatment and Prevention of diseases, as well as the use of these ADCS for the preparation of drugs for the treatment and / or prevention of diseasesIn particular, angiogenic and / or hyperproliferative diseases such as cancer.These treatments can be performed as monotherapy or in combination with other medications and other Therapeutic measures.Claim 1: Conjugate of an Antibody with one or more Molecules of the active principle of the formula (2),Where represents a Linker Antibody anti tweakr agonist agonist Action moderately or not or one of its Fragments Binding to Antigen; l represents a Linker; n is a number1 to 1.2 to 20 and 50, preferably with Special preference, 2 to 8; and KSP is a compound of the formula (1), where ru00b9 represents - H, - L - # Mod 1, - O - (chu2082) u2080u208bu2083z, where z represents h,- nhyu00b3, oyu00b3 syu00b3 halogen -, -, - C (= o) - nyu00b9yu00b2 or - C (= o) - oyu00b3; yu00b9 and yu00b2 represent, independently of each other, - H, - nhu2082, - (chu2082chu2082o) u2080u208bu2083 - (chu2082) u2080u208bu2083z '(e.g.- (chu2082) u2080u208bu2083z ') or CH (chu2082w) Z'; or (chu2082 represents - H OR - '' represents u2080u208bu2083z); Z - H, - nhu2082, - COOH, - sou2083h,- NH - C (= o) - chu2082 - chu2082 - COOH and - ch (nhu2082) (CO NH - chyu2074) u2081u208bu2083cooh; W represents H or Oh; yu2074 cu2081u208bu2086 represents linear or branched alkyl, optionally substituted with - NH - C (= o) - nhu2082,Or - or benzyl aryl optionally replaced with nhu2082; Ru00b2 represents h, mod -, - C (= o) - O - (chyu2074 - nhyu2075 u2080u208bu2083z chu2082), where z represents h, halogen, oyu00b3 syu00b3 -, -, - nhyu00b3,- C (= o) - nyu00b9yu00b2 or - C (= o) - oyu00b3; yu00b9 and yu00b2 represent, independently of each other, - H, - or - nhu2082 (chu2082 represents u2080u208bu2083z '); or - H OR - (chu2082) u2080u208bu2083z' represents'; Z - H, - sou2083h,- nhu2082 or - COOH; yu2074 cu2081u208bu2086 represents linear or branched alkyl, optionally substituted with - NH - C (= o) - nhu2082,Or optionally substituted aryl or benzyl yu2075 represents nhu2082 with - and - H OR - C (= o) - chyu2076 - nhu2082; yu2076 represents linear or branched alkyl cu2081u208bu2086; ru2074 represents # - H, - L - 1, - sgu2097u02b8u209b - (c = o) - u2080u208bu2081 ru2074 ',- C (= o) - O - (chyu2074 - nhyu2075 chu2082) u2080u208bu2083z, Where Where sgu2097u02b8u209b represents a Group cleavable by lysosomal Enzymes, particularly a group composed of a Di - or tripeptide,Where ru2074 'cu2081u208bu2081u2080 represents an alkyl, aryl or cu2085u208bu2081u2080 aralquilo cu2086u208bu2081u2080, heteroalquilo cu2085u208bu2081u2080, alkyl - or aryl - cu2081u208bu2081u2080 cu2086u208bu2081u2080, heterocicloalquilo cu2085u208bu2081u2080 heteroaryl heteroaryl alkyl,,,Heteroaryl - alkoxy -, alkoxy cu2081u208bu2081u2080, ariloxi cu2086u208bu2081u2080 or aralcoxi cu2086u208bu2081u2080, heteroaralcoxi cu2085u208bu2081u2080 cu2081u208bu2081u2080, alkyl - or - ariloxi cu2086u208bu2081u2080, heterocicloalcoxi cu2085u208bu2081u2080, which can be polisustituido with mono - or - nhu2082,- NH - N - alkyl (alkyl) u2082, - NH - C (= o) - alkyl (alkyl) - N - C (= o) - sou2083h alkyl -, - S - (= o) u2082 nhu2082, S (= o) - (alkyl) - n u2082 u2082, - COOH, - C (= o) - nhu2082, - C (= o) - (alkyl) - n u2082 or Oh.- H OR - represents a Group ou02e3 - (chu2082chu2082o) u02b8 - ru2074 ', where X is 0 OR 1, where V represents a number from 1 to 10, where ru2074' represents h, alkyl (alkyl preferably cu2081u208bu2081u2082) - chu2082 - COOH,Chu2082 chu2082 - COOH and - - - - - chu2082 chu2082 nhu2082; where z represents h, halogen, oyu00b3 syu00b3 nhyu00b3 -, -, - C (= o) - nyu00b9yu00b2 or - C (= o) - oyu00b3, where yu00b9 and yu00b2 represent, independently of each other, - H nhu2082, - O - (chu2082) u2080u208bu2083z ',Where is or - H OR - (chu2082) u2080u208bu2083z ', where z represents sou2083h' - H, - or - COOH, - nhu2082; where yu2074 represents linear or branched alkyl cu2081u208bu2086,Optionally replaced with - NH - C (= o) - nhu2082 or aryl benzyl or optionally substituted with - nhu2082,Where yu2075 represents - H OR - C (= o) - chyu2076 - nhu2082 and where yu2076 represents linear or branched alkyl cu2081u208bu2086; or Ru00b2 and ru2074 represent Together (with formation of a pyrrolidine Ring chu2082 chru00b9u00b9) - - - - - - or chru00b9u00b9 chu2082,Where ru00b9u00b9 represents - H, - nhu2082 sou2083h, - SH, - COOH, - Halogen (F, CL, or in Special cu2081u208bu2084 haloalquilo cu2081u208bu2084) alkyl, alkoxy, substituted with alkyl cu2081u208bu2084, cu2081u208bu2084 hydroxylCoo (cu2081u208bu2084 or alkyl) - Oh, - C (= o) - (= o) - S, - S, - u2082 (= o) -, S - (= o) - (u2082nh or - C = N - nhu2082); ru00b3 represents # - L - 1, - mod or an alkyl group, cycloalkyl, aryl, heteroaryl, heteroalquilo,Heterocicloalquilo optionally replaced, preferably # - L - 1 or an aryl or alkyl group cu2081u208bu2081u2080, cu2086u208bu2081u2080 aralquilo cu2086u208bu2081u2080, heteroalquilo cu2085u208bu2081u2080,Cu2081u208bu2081u2080 alkyl - or aryl - or cu2086u208bu2081u2080 heterocicloalquilo cu2085u208bu2081u2080, which in each case may be substituted with groups 1 - 3 - 1 - 3 Halogen Atoms.1 - 3 (Halogenated alkyl groups present in each case 1 - 3 Halogen Atoms), 1 - 3 - alkyl groups or - SH groups, 1 - 3, 1 - 3 - alkyl groups, groups 1 - 3 or - C (= o) - alkyl1 - 3 Groups - or - C (= o) - alkyl - NH - NH groups, 1 - 3 - C (= o) - alkyl groups 1 - 3, - NH - C (= o) - NH - alkyl groups, 1 - 3 - S (= o) - alkyl u2099, 1 - 3 Groups - S (= o) - alkyl u2082 - NH - NH groups, 1 - 3 - alkyl1 - 3 groups (alkyl) - n u2082, 1 - 3 - 1 - 3 nhu2082 groups or groups (u2080u208bu2083z chu2082), where n represents 0, 1 or 2; Z represents h, halogen - oyu00b3 syu00b3 nhyu00b3, -, -, - C (= o) - O - nyu00b9yu00b2 C (= o) - oyu00b3 yu00b9 yu00b2 represent; and,Independently of each other, - H, - or - nhu2082 (chu2082 represents u2080u208bu2083z '); or - H, - (chu2082 u2080u208bu2083 - ch (NH) - C (= o) - chu2083) Z' - (chu2082) u2080u208bu2083 - ch (nhu2082) Z - (chu2082 u2080u208bu2083z 'Or') 'h; Z represents sou2083h -, - or - COOH, - nhu2082; ru2075 represents h,- nhu2082, - nou2082 (in particular, halogen (F, CL, BR), - CN, - cfu2083, ocfu2083 chu2082f chu2082f, -, -, or - SH (chu2082) u2080u208bu2083z, where z represents oyu00b3 - H, -, - syu00b3, halogen, nhyu00b3 -, - C (= o) - nyu00b9yu00b2 or - C (= o) - oyu00b3, yu00b9 and yu00b2 representIndependently of each other, - H, - or - nhu2082 (chu2082 u2080u208bu2083z '); or (chu2082 represents - H OR -' ') u2080u208bu2083z; Z represents sou2083h - H, -, - and - COOH or nhu2082; ru2076 ru2077 represent, independently of each other, - H, cyano,Cu2081u208bu2081u2080 fluoro alkyl, alkyl cu2081u208bu2081u2080, alquenilo cu2082u208bu2081u2080, fluoro alquenilo cu2082u208bu2081u2080, alquinilo cu2082u208bu2081u2080 alquinilo cu2082u208bu2081u2080, fluoro -, hydroxy - nou2082 nhu2082, - COOH, - ru2078 represents alkyl or Halogen; cu2081u208bu2081u2080,Fluoro alkyl cu2081u208bu2081u2080, alquenilo cu2082u208bu2081u2080, fluoro alquenilo cu2082u208bu2081u2080, alquinilo cu2082u208bu2081u2080, fluoro alquinilo cu2082u208bu2081u2080, cycloalkyl or cycloalkyl cu2084u208bu2081u2080 cu2084u208bu2081u2080, fluoro - (chu2082) u2080u208bu2082 - (hzu00b2)That may be mono - or di, identical or different, - Oh, - COOH and - nhu2082 and where hzu00b2 represents a heterocycle of 4 to 7 members with up to two heteroatoms selected from N,O and S; ru2079 represents - H, - F, - chu2083, cfu2083 chu2082f -, - or - chfu2082; where one of the substituents ru00b9, ru00b3 and ru2074 represents # - L - 1,L represents a Linker and # 1 represents the link with the Antibody; mod represents - (nru00b9u2070) u2099 - (gu00b9) u2092 - G - gu00b3, where ru00b9u2070 represents H or alkyl cu2081u208bu2083; gu00b9 represents - NHC (= o) -,- C (= o) - NH - (which is when gu00b9 - NHC (= o) - then ru00b9u2070 is not nhu2082); n is 0 OR 1; or is 0 OR 1; and G is a linear or branched Hydrocarbon chain with 1 to 10 carbon ATOMS,That can be interrupted once or several times by one or several of the groups - O -, - S - S - (= o) - O - (= o) - - - u2082, nru02b8, nru02b8c (= o) -, - C (= o) - - - - nru02b8, nru02b8nru02b8 - S, - nru02b8nru02b8 u2082 (= o) -, - C (= o) - nru02b8nru02b8 -- Where ru02b8 represents h, alkyl, phenyl or cu2081u208bu2081u2080, alquenilo cu2082u208bu2081u2080 alquinilo cu2082u208bu2081u2080, which may be mono - or polisustituidos, identical or different, with - NH - C (= o) - nhu2082, - COOH, - Oh, - nhu2082, - NH - cnnhu2082,Sulfonamide and sulfonic acid sulfoxide, sulfone, and / or may be one or several times interrupted by the same or different, - C (= o) - O - N - cru02e3 =, where represents ru02e3 - HCu2081u208bu2083 alkyl or phenyl, and where the Hydrocarbon Chain including an alkyl group cu2081u208bu2081u2080 optionally substituted Hydrocarbon Group as in the side chainCan be replaced with - NH - C (= o) - nhu2082, - COOH, - Oh, - nhu2082, - NH - cnnhu2082, sulfonamide, sulphoneSulfoxide or sulfonic acid; gu00b3 represents - H OR - COOH Group; and where the mod is preferably at least a - COOH Group; as well as their salts, solvates, Salts and solvates of the epu00edmeros.
机译:本申请涉及共轭连接物-活性成分(ADCS),这些ADCS的活性代谢物,制备这些ADCS的程序,这些ADCS在治疗和预防疾病中的用途以及这些ADCS在制备药物中的用途用于治疗和/或预防疾病特别是血管生成和/或过度增生的疾病,例如癌症。这些治​​疗可以作为单一疗法或与其他药物和其他治疗措施结合进行。要求1:抗体与一种抗体的结合或具有式(2)的活性原理的分子,其中表示连接体抗体抗调节剂激动剂激动剂的作用是否适度或其结合抗原的片段之一; l表示链接器; n为1至1.2至20和50,特别优选2至8;并且KSP是式(1)的化合物,其中r u00b9代表-H,-L-#Mod 1,-O-(ch u2082) u2080 u208b u2083z,其中z代表h,-nhy u00b3,oy u00b3 sy u00b3卤素-,-,-C(= o)-ny u00b9y u00b2或-C(= o)-oy u00b3; y u00b9和y u00b2彼此独立地表示-H,-nh u2082,-(ch u2082ch u2082o) u2080 u208b u2083-(ch u2082) u2080 u208b u2083z'(例如-(ch u2082) u2080 u208b u2083z')或CH(ch u2082w)Z';或(ch u2082代表-H或-''代表 u2080 u208b u2083z); Z-H,-nh u2082,-COOH,-so u2083h,-NH-C(= o)-ch u2082-ch u2082-COOH和-ch(nh u2082)(CO NH-chy u2074 ) u2081 u208b u2083cooh; W代表H或Oh; y u2074 c u2081 u208b u2086表示直链或支链烷基,可选地被-NH-C(= o)-nh u2082取代,或-或苄基芳基,可选地被nh u2082取代; R u00b2代表h,mod-,-C(= o)-O-(chy u2074-nhy u2075 u2080 u208b u2083z ch u2082),其中z代表h,卤素,oy u00b3 sy u00b3 -,-,-nhy u00b3,-C(= o)-ny u00b9y u00b2或-C(= o)-oy u00b3; y u00b9和y u00b2彼此独立地表示-H,-或-nh u2082(ch u2082表示 u2080 u208b u2083z');或-H或-(ch u2082) u2080 u208b u2083z'代表'; Z-H,-so u2083h,-nh u2082或-COOH; y u2074 c u2081 u208b u2086表示直链或支链烷基,可选被-NH-C(= o)-nh u2082取代,或可选被取代的芳基或苄基y u2075表示具有-和-H的nh u2082或-C(= o)-chy u2076-nh u2082; y u2076表示直链或支链烷基c u2081 u208b u2086; r u2074代表#-H,-L-1,-sg u2097 u02b8 u209b-(c = o)- u2080 u208b u2081 r u2074',-C(= o)-O-(chy u2074-nhy u2075 ch u2082) u2080 u208b u2083z,其中sg u2097 u02b8 u209b表示可被溶酶体酶裂解的基团,特别是由Di-或三肽组成的基团,其中r u2074' c u2081 u208b u2081 u2080代表烷基,芳基或c u2085 u208b u2081 u2080 aralquilo c u2086 u208b u2081 u2080,杂芳基c u2085 u208b u2081 u2080,烷基或芳基-c u2081 u208b u2081 u2080 c u2086 u208b u2081 u2080,杂环烷基c u2085 u208b u2081 u2080杂芳基杂芳基烷基,,,杂芳基-烷氧基-,烷氧基c u2081 u208b u2081 u2080,ariloxi c u2086 u208b u2081 u2080或aralcoxi c u2086 u208b u2081 u2080,heteraralcoxi c u2085 u208b u2081 u2080 c u2081 u208b u2081 u2080,烷基-或-ariloxi u2086 u208b u2081 u2080,异环丙稀c u2085 u208b u2081 u2080,可以是具有单-或-nh u2082,-NH-N-烷基(烷基)的polisustituituido u2 082,-NH-C(= o)-烷基(烷基)-N-C(= o)-so u2083h烷基-,-S-(= o) u2082 nh u2082,S(= o)-(烷基)-n u2082 u2082,-COOH,-C(= o)-nh u2082,-C(= o)-(烷基)-n u2082或Oh。-H OR-代表基团o u02e3 -(ch u2082ch u2082o) u02b8-r u2074',其中X为0或1,其中V表示1到10的数字,其中r u2074'代表h,烷基(烷基优选c u2081 u208b u2081 u2082)-ch u2082-COOH,Ch u2082 ch u2082-COOH和-----ch u2082 ch u2082 nh u2082;其中z代表h,卤素,oy u00b3 sy u00b3 nhy u00b3-,-,-C(= o)-ny u00b9y u00b2或-C(= o)-oy u00b3,其中y u00b9和y u00b2彼此独立地表示-H nh u2082,-O-(ch u2082) u2080 u208b u2083z',在哪里或--H OR-(ch u2082) u2080 u208b u2083z' ,其中z代表so u2083h'-H,-或-COOH,-nh u2082;其中y u2074表示直链或支链烷基c u2081 u208b u2086,可选用-NH-C(= o)-nh u2082或芳基苄基取代,或可选用-nh u2082取代,其中y u2075表示- H OR-C(= o)-chy u2076-nh u2082,其中y u2076表示直链或支链烷基c u2081 u208b u2086;或R u00b2和r u2074一起代表(形成吡咯烷环ch u2082 chr u00b9 u00b9)-----或chr u00b9 u00b9 ch u2082,其中r u00b9 u00b9代表- H,-nh u2082 so u2083h,-SH,-COOH,-卤素(F,CL或特殊c u2081 u208b u2084卤代alquilo c u2081 u208b u2084)烷基,烷氧基,被烷基c u2081 u208b u2084,c u2081 u208b u2084羟基Coo取代(c u2081 u208b u2084或烷基)-哦,-C(= o)-(= o)-S,-S ,- u2082(= o)-,S-(= o)-( u2082nh或-C = N-nh u2082); r u00b3代表#-L-1-修饰基或烷基,环烷基,芳基,杂芳基,杂芳基,杂氯杂环基,可选取代,优选#-L-1或芳基或烷基c u2081 u208b u2081 u2080 ,c u2086 u208b u2081 u2080 aralquilo c u2086 u208b u2081 u2080,杂芳基c u2085 u208b u2081 u2080,C u2081 u208b u2081 u2080烷基-或芳基-或c u2086 u208b u2081 u2080异环氯喹啉c u2085 u208b u2081 u2080,在每种情况下均可被1-3-3个卤素原子取代。1-3(在每种情况下均存在1-3个卤代烷基)卤素原子),1-3个烷基或-SH基团,1-3、1-3个烷基,1-3个基团或-C(= o)-烷基1-3个基团-或-C(= o) -烷基-NH-NH基,1-3-C(= o)-烷基1-3,-NH-C(= o)-NH-烷基,1-3-S(= o)-烷基 u2099、1-3个基团-S(= o)-烷基 u2082-NH-NH基团,1-3-烷基1-3个基团(烷基)-n u2082、1-3-1-3 nh u2082基团或群组( u2080 u20 8b u2083z ch u2082),其中n代表0、1或2; Z代表h,卤素-oy y u00b3 y u00b3,-,-,-C(= o)-O-ny u00b9y u00b2 C(= o)-oy u00b3 y u00b9 y u00b2代表;并且,彼此独立地为-H,-或-nh u2082(ch u2082表示 u2080 u208b u2083z');或-H,-(ch u2082 u2080 u208b u2083-ch(NH)-C(= o)-ch u2083)Z'-(ch u2082) u2080 u208b u2083-ch(nh u2082)Z-(ch u2082 u2080 u208b u2083z'Or')'h; Z代表-,-或-COOH,-nh u2082; r u2075代表h,-nh u2082,-否 u2082(特别是卤素(F,CL,BR),-CN,-cf u2083,ocf u2083 ch u2082f ch u2082f,-,-,或-SH(ch u2082) u2080 u208b u2083z,其中z代表oy u00b3-H,-,-sy u00b3,卤素,nhy u00b3-,-C(= o)-ny u00b9y u00b2或-C(= o)-oy u00b3,y u00b9和y u00b2彼此独立地表示-H,-或-nh u2082(ch u2082 u2080 u208b u2083z');或(ch u2082代表-H OR-'') u2080 u208b u2083z; Z代表so u2083h-H,-,-和-COOH或nh u2082; r u2076 r u2077彼此独立地代表-H ,氰基,C u2081 u208b u2081 u2080氟代烷基,烷基c u2081 u208b u2081 u2080,alquenilo c u2082 u208b u2081 u2080,氟代alquenilo c u2082 u208b u2081 u2080,alquinilo c u2082 u208b u2081 u2080 Alquinilo c u2082 u208b u2081 u2080,氟-羟基-no u2082 nh u2082,-COOH,-r u2078代表烷基或卤素; c u2081 u208b u2081 u2080,氟烷基c u2081 u208b u2081 u2080,alquenilo c u2082 u208b u20 81 u2080,氟代alquenilo c u2082 u208b u2081 u2080,alquinilo c u2082 u208b u2081 u2080,氟代alquinilo c u2082 u208b u2081 u2080,环烷基或环烷基c u2084 u208b u2081 u2080 c u2084 u208b u2081 u2080,氟-(ch u2082) u2080 u208b u2082-(hz u00b2)可以是单-或di,相同或不同,-哦,-COOH和-nh u2082,其中hz u00b2代表4至7个成员的杂环,其中最多有两个选自N,O和S的杂原子; r u2079代表-H,-F,-ch u2083,cf u2083 ch u2082f-,-或-chf u2082;其中取代基r u00b9,r u00b3和r u2074之一表示#-L-1,L表示连接基,#1表示与抗体的连接; mod代表-(nr u00b9 u2070) u2099-(g u00b9) u2092-G-g u00b3,其中r u00b9 u2070代表H或烷基c u2081 u208b u2083; g u00b9代表-NHC(= o)-,-C(= o)-NH-(这是g u00b9-NHC(= o)-那么r u00b9 u2070不是nh u2082); n为0或1;或为0或1;或G是具有1至10个碳原子的ATOMS的直链或支链烃链,可被一个或几个基团-O-,-S-S-(= o)-O-(= o )--- u2082,nr u02b8,nr u02b8c(= o)-,-C(= o)----nr u02b8,nr u02b8nr u02b8-S,-nr u02b8nr u02b8 u2082 (= o)-,-C(= o)-nr u02b8nr u02b8-其中r u02b8代表h,烷基,苯基或c u2081 u208b u2081 u2080,alquenilo c u2082 u208b u2081 u2080 alquinilo c u2082 u208b u2081 u2080,可以是相同或不同的单-或polisustituitus,具有-NH-C(= o)-nh u2082,-COOH,-哦,-nh u2082,- NH-cnnh u2082,磺酰胺和磺酸亚砜,砜和/或可以被相同或不同的基团打断一次或多次,-C(= o)-O-N-cr u02e3 =,其中r u02e3-HC u2081 u208b u2083烷基或苯基,并且其中烃链包括烷基c u2081 u208b u2081 u2080任选取代的烃基,如侧链C可以用-NH-C(= o)-nh u2082,-COOH,-哦,-nh u2082,-NH-cnnh u2082,磺酰胺,砜亚砜或磺酸代替; g u00b3代表-H OR-COOH基团;其中mod优选至少为-COOH基团;以及它们的盐,溶剂化物,上次盐的盐和溶剂化物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号